Ghallab and Shaker assessed the ability of MMP9 salivary levels to differentiate between patients with OSCC and an OPMD, reporting a sensitivity and specificity of 100% [15]. This evidence concerns the gene MMP9 and oculopharyngeal muscular dystrophy.